Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Vontier
VNT
$6.36B
| $45.7M | 0.07% |
1,006,500
+60,800
| +6% | +$2.76M |
|
327
Masco
MAS
$15.9B
| $45.6M | 0.07% |
577,500
+206,700
| +56% | +$16.3M |
|
328
Kyndryl
KD
$7.66B
| $45.5M | 0.07% |
2,090,000
+43,200
| +2% | +$940K |
|
329
Supernus Pharmaceuticals
SUPN
$2.57B
| $45.5M | 0.07% |
1,333,222
-45,200
| -3% | -$1.54M |
|
|
BSCO
330
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $45.2M | 0.07% |
2,157,596
+584,328
| +37% | +$12.3M |
|
331
State Street
STT
$31.7B
| $45.2M | 0.07% |
+584,331
| New | +$45.2M |
|
332
Buckle
BKE
$3.04B
| $44.9M | 0.07% |
1,114,102
+40,100
| +4% | +$1.61M |
|
333
Janus Henderson Short Duration Income ETF
VNLA
$2.76B
| $44.8M | 0.07% |
923,900
-19,400
| -2% | -$941K |
|
334
International Seaways
INSW
$2.35B
| $44.6M | 0.07% |
838,331
+88,000
| +12% | +$4.68M |
|
335
Interactive Brokers
IBKR
$27.2B
| $44.5M | 0.07% |
1,594,000
+991,200
| +164% | +$27.7M |
|
336
Nextracker
NXT
$10.3B
| $44.5M | 0.07% |
789,956
+486,356
| +160% | +$27.4M |
|
337
Quanex
NX
$743M
| $44.4M | 0.07% |
1,156,007
-2,100
| -0.2% | -$80.7K |
|
338
Unum
UNM
$12.6B
| $44.4M | 0.07% |
827,400
+378,600
| +84% | +$20.3M |
|
339
Applovin
APP
$189B
| $44.1M | 0.07% |
636,600
+334,100
| +110% | +$23.1M |
|
340
Abercrombie & Fitch
ANF
$4.49B
| $43.9M | 0.07% |
350,400
+204,400
| +140% | +$25.6M |
|
341
Oscar Health
OSCR
$5.18B
| $43.9M | 0.07% |
2,951,500
+106,500
| +4% | +$1.58M |
|
342
Hims & Hers Health
HIMS
$10.8B
| $43.8M | 0.07% |
2,834,300
+2,184,127
| +336% | +$33.8M |
|
343
Dow Inc
DOW
$17B
| $43.8M | 0.07% |
755,400
-97,100
| -11% | -$5.62M |
|
344
TripAdvisor
TRIP
$2.02B
| $43.7M | 0.07% |
1,573,110
-225,300
| -13% | -$6.26M |
|
345
Ford
F
$45.7B
| $43.6M | 0.07% |
3,286,709
+332,800
| +11% | +$4.42M |
|
346
Takeda Pharmaceutical
TAK
$48.2B
| $43.3M | 0.07% |
3,118,200
-209,200
| -6% | -$2.91M |
|
|
IBTE
347
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
| $43.2M | 0.07% |
1,802,701
+480,189
| +36% | +$11.5M |
|
348
Rio Tinto
RIO
$101B
| $43.1M | 0.07% |
+676,000
| New | +$43.1M |
|
349
Dillards
DDS
$9.03B
| $43.1M | 0.07% |
91,300
+15,600
| +21% | +$7.36M |
|
350
TFS Financial
TFSL
$3.84B
| $42.8M | 0.07% |
3,407,356
-165,300
| -5% | -$2.08M |
|